Department of Pediatrics

We are committed to giving children a bright future. We provide the highest-quality clinical care, and we improve it every day through scientific research and training tomorrow's pediatrics leaders.

About Us

Welcome! For over a century, faculty at Emory University have provided clinical care to children in Georgia. The Department of Pediatrics is committed to providing the best clinical care, cutting-edge research, and training opportunities for tomorrow's pediatric leaders.

Quick Links

For Patients

Residents & Fellows

Future Talent

Pediatrics Intranet

Clinical Care

From rare diseases to routine procedures, we provide advanced treatment for children and teens through our clinical facilities at Children's Healthcare of Atlanta

Leading the way in pediatric health

#1 in 2022 NIH funding

We rank among the top pediatrics departments in the U.S. for National Institutes of Health funding awards.

4 Specialties in Top 10: U.S. News & World Report 2022-2023

The Cancer Program (No. 7), the Gastroenterology and GI Surgery Program (No. 7), the Nephrology Program (No. 9) and the Urology Program (No. 10).

73 children cured of sickle cell

The largest sickle cell program in the nation gives children suffering from the disease a healthy new future.

400+ clinical trials for pediatric cancer

Our Aflac Cancer and Blood Disorders Center has one of the largest brain tumor and leukemia-lymphoma programs in the U.S.

Pediatrics News

Emory School of Nursing receives gift to train pediatric psychiatric mental health nurse practitioners May. 16, 2023

Emory University’s Nell Hodgson Woodruff School of Nursing is partnering with the Liz Blake Giving Fund and Children’s Healthcare of Atlanta (Children’s) to develop a scholarship program to expand and equip the workforce of pediatric mental health professionals.

Treating trauma across a lifespan Apr. 10, 2023

During the 2023 Hamilton E. Holmes, MD, Memorial Lecture, three Emory experts shared lessons they’ve learned about treating and helping others move beyond trauma.

Researchers find lorlatinib to be safe and effective treatment for high-risk neuroblastoma Apr. 3, 2023

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Winship Cancer Institute researcher Kelly Goldsmith, MD, has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.

Events

More Events

Loading Events...